Nationwide Study Reveals Critical Gaps in HPV Cancer Awareness, Particularly in Midwest and South
核心洞察
A nationwide study of 22,344 adults found that 34.3% are unaware of HPV and 37.6% lack awareness of the HPV vaccine, with the highest rates of unawareness in Midwestern and Southern states.
Among those familiar with HPV, 70.8% did not know it causes oral cancers and 28.3% were unaware of its link to cervical cancer, representing significant knowledge gaps about HPV's role in cancer development.
The findings are particularly concerning given that nearly 62% of the estimated 48,000 annual HPV-associated cancer cases occur in the Midwest and South, where awareness levels are lowest.
A comprehensive analysis of national survey data reveals alarming gaps in public awareness about human papillomavirus (HPV) and its connection to cancer, with particularly low knowledge levels in regions where HPV-associated cancers are most prevalent. The study, published in JAMA Oncology, found that more than one-third of American adults remain unaware of HPV or the HPV vaccine despite the virus causing an estimated 48,000 new cancer cases annually.
Geographic Disparities in HPV Awareness
Researchers from MUSC Hollings Cancer Center (搜索) analyzed responses from 22,344 adults aged 18 and older using data from the Health Information National Trends Survey (HINTS) conducted between 2017-2022. The study population had a mean age of 49 years, with 51.1% being female participants.
The findings revealed striking geographic patterns in awareness levels. Nationwide, 34.3% (95% CI, 33.2%-35.4%) were unaware of HPV, while 37.6% (95% CI, 36.5%-38.8%) lacked awareness of the HPV vaccine. The lack of HPV awareness exceeded 40% in seven states, primarily concentrated in the Midwest (Kansas, Nebraska, and Illinois) and the South (Mississippi, Arkansas, and Alabama).
Even more concerning, more than 40% of individuals across 13 states were unaware of the HPV vaccine, including nine states across the Midwest (South Dakota, Kansas, and Illinois) and the South (Alabama, Arkansas, Florida, Oklahoma, South Carolina, and Mississippi).
Cancer Knowledge Gaps Persist
Among participants who had heard of HPV, significant knowledge gaps remained regarding its role in cancer development. The study found that 70.8% (95% CI, 69.2%-72.3%) were unaware that HPV causes oral cancers, while 28.3% (95% CI, 27.0%-29.6%) did not know it causes cervical cancer.
The researchers suggested this disparity may reflect the historical focus on cervical cancer in screening programs and early vaccine campaigns, while oral cancer has received less public attention. HPV is known to cause six types of cancer: anal, cervical, oropharyngeal, penile, vaginal, and vulvar cancers.
Clinical Significance and Regional Impact
The awareness gaps are particularly troubling given that nearly 62% of all new HPV-associated cancers in the United States are diagnosed in the Midwest and South, the same regions showing the lowest awareness levels. These areas have recently experienced rising rates of HPV-associated cancers and related deaths.
HPV affects approximately 43 million people annually in the United States, making it the most common sexually transmitted infection in the country. While most infections are cleared by the immune system, persistent infection with high-risk HPV types can lead to cellular changes that develop into cancer.
Vaccination and Prevention Challenges
The HPV vaccine represents the most effective protection against HPV infection and associated cancers. Gardasil 9, currently the only HPV vaccine available in the United States, protects against nine HPV types, including high-risk strains responsible for the majority of HPV-related cancers. The vaccine is recommended for both boys and girls starting at age 11 or 12, with catch-up vaccination advised through age 26.
Despite the vaccine's proven effectiveness in reducing cervical cancer rates—contributing to a nearly 50% decline in incidence and 70% drop in mortality since the 1950s—uptake remains suboptimal, particularly in regions with low awareness levels.
Public Health Implications
The researchers emphasized that awareness serves as a "key psychosocial factor" influencing public adherence to preventive measures like vaccination. Low HPV vaccine awareness is especially concerning in the Midwest and South, where vaccination rates are already suboptimal.
The study authors concluded that "given the importance of timely HPV vaccination and the risk of early-life exposure, there is a critical need to enhance HPV awareness among adolescents, young adults, parents or caregivers, and pediatric and adult health care professionals."
Public health experts warn that addressing these disparities will require overcoming persistent vaccine skepticism and misinformation, which continue to hinder vaccination rates. Without greater awareness, acceptance, and timely immunization, preventable HPV-related cancers will continue to rise despite the availability of a safe and effective preventive tool.